Skip to main content
SpringerLink
Log in

Benzodiazepines and new non-benzodiazepine agents

  • Chapter
Book cover Sleep

  • 706 Accesses

Abstract

The definition of insomnia changes and broadens over time - proof that it is still not completely understood by patients and clinicians. Added to complaints of sleep onset difficulties, and insufficient sleep and recurrent nocturnal awakenings, are those of daytime sleepiness, fatigue, irritability, lack of concentration and inadequate performance. Many chronic insomniacs complain of daytime sleepiness and this may constitute a risk factor, in terms of accidents at home and at work, and the costs to society.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. ALLAIN H., DELAHAYE CH., LE COZ F., BLIN P., DECOMBE R., MARTINET J.P. - Postmarketing surveillance of zopiclone in insomnia: analysis of 20 513 cases. Sleep, 14, 408–413, 1991.

    PubMed  CAS  Google Scholar 

  2. AMERICAN PSYCHIATRIC ASSOCIATION - Benzodiazepine: Dependence, toxicity and abuse. A Task Force Report. 1st ed., American Psychiatric Association, Washington, DC, 1990.

    Google Scholar 

  3. AMERICAN PSYCHIATRIC ASSOCIATION - Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Association, Washington D.C., 1994.

    Google Scholar 

  4. ARBILLA S., ALLEN J., WICK A., LANGER S.Z. - High affinity (3 H) zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors. Eur. J. Pharmacol, 130, 257–263, 1986.

    Article  PubMed  CAS  Google Scholar 

  5. ARBILLA S., DEPOORTERE H., GEORGE P., LANGER S.Z. - Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats. N. S. Arch. Pharmacol., 530, 248–251, 1985.

    Article  Google Scholar 

  6. BALTER M. - What are the prevalence and characteristic of insomnia? Insomnia Research Bulletin. WFSRS Founding Congress, 1, 1991.

    Google Scholar 

  7. BEER B., CLODY D.E., MANGANO R., LEVNER M., MAYER P., BARRETT J.E. - A review of the preclinical development of zaleplon, a novel non-benzodiazepine hypnotic for the treatment of insomnia. CNS Drug reviews 3, 207–224, 1997.

    Article  CAS  Google Scholar 

  8. BENOÎT O., BOUARD G., PAYAN C., BORDERIES P., PRADO J. - Effect of a single dose (10 mg) of zolpidem on visual and spectral analysis of sleep in young poor sleepers. Psychopharmacology, 116, 297–303, 1994.

    Article  PubMed  Google Scholar 

  9. BILLIARD M., BESSET A., DE LUSTRAC C., BRISSAUD L. - Dose-response effects of zopiclone on night sleep and on night-time and day-time functioning. Sleep, 10 (suppl., 26–34), 1987.

    Google Scholar 

  10. BORBÉLY A.A. - Principles of sleep regulation: Implications for the effect of hypnotics on sleep. In: The pharmacology of sleep. A. Kales (ed.). Springer, Berlin, 29–45, 1995.

    Chapter  Google Scholar 

  11. BORBÉLY A.A., MATTMANN P., LOEPFE M., STRAUCH I., LEHMANN D. - Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Human Neurobiol., 4, 189–194, 1985.

    Google Scholar 

  12. BORMANN J. - Electrophysiology of GABAa and GABAb receptor subtypes. Trends Neurosci, 11, 112–113, 1988.

    Article  PubMed  CAS  Google Scholar 

  13. BRUNNER D.P., DIJK D.J., MUNCH M., BORBELY A.A. - Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology, 104, 1–5, 1991.

    Article  PubMed  CAS  Google Scholar 

  14. BUYSSE D.J., REYNOLDS C.F., KUPFER D.J., THORPY M.J., BIXLER E., MANFREDI R., KALES A., VGONTZAS A., STEPANSKI E., ROTH T., HAURI P., MESIANO D. - Clinical diagnoses in 216 insomnia patients using the international classification of sleep disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NINM field trial. Sleep, 17, 630–637, 1994.

    PubMed  CAS  Google Scholar 

  15. COLEMAN R.M. - Diagnosis, treatment and follow-up of about 8 000 sleep/wake disorder patients. In: Sleep/wake disorders: natural history epidemiology, and long-term evolution. C. Guilleminault, E. Lugaresi (eds.). Raven Press, New York, 87–97,1983.

    Google Scholar 

  16. DECLERCK A.C., RUWE F., O’HANLON J.F., WAU-QUIER A. - Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia. Psychopharmacology, 106, 497–501, 1992.

    Article  PubMed  CAS  Google Scholar 

  17. DENNIS T., DUBOIS A., BENAVIDES J., SCATTON B. - Distribution of central wl (benzodiazepine 1) and w2 (benzodiazepine 2) receptor subtypes in the monkey and human brain. An autoradiographic study with (3H) zolpidem and the wl selective ligand (3H) flunitrazepam. J. Pharmacol. Exptl. Ther., 247, 309–322, 1988.

    CAS  Google Scholar 

  18. DEPOORTERE H., ZIVKOVIC B., LLOYD KG., SANGERD.J., PERRAULT G. - Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J. Pharmacol. Exptl. Ther., 237, 649–658, 1986.

    CAS  Google Scholar 

  19. AMERICAN SLEEP DISORDERS ASSOCIATION.- ICSD - International Classification of Sleep Disorders: diagnostic and coding manual. American Sleep Disorders Association: Rochester, 1997.

    Google Scholar 

  20. DIJK D.J., BEERSMA D.G.M., DAAN S., VAN DEN HOOFDAKKER R.H. - Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur. J. Pharmacol., 171, 207–218, 1989.

    Article  PubMed  CAS  Google Scholar 

  21. CONSENSUS CONFERENCE. Drugs and insomnia. JAMA, 21, 2410–2414, 1984.

    Google Scholar 

  22. ELIE R., DAVIGNON M., EMILIEN G. - Zaleplon decreases sleep latency in outpatients without producing rebound insomnia after 4 weeks of treatment. J. Sleep Res. 7 (Suppl. 2): 76, 1998.

    Google Scholar 

  23. FEINBERG I., MALONEY T., CAMPBELL I. - Period-amplitude analysis (PAA) of amplitude and incidence of NREM EEG under zolpidem (Z), triazolam (Tr) and temazepam (Te) for delta (0.3–3 Hz), sigma (12–15 Hz) and beta (15–23 Hz) frequencies, Sleep Res., 24A, 123, 1995.

    Google Scholar 

  24. FERRILLO F., BALESTRA V., DE CARLI F., MANFREDI C., PISCHEDDA G.G., ROSADINI G. - Effects of the administration of zolpidem and triazolam on the dynamics of EEG slow waves during sleep. J. Sleep Res., 7 (suppl. 1), 72, 1992.

    Google Scholar 

  25. GARZONE P.D., KROBOTH P.D. - Pharmacokinetics of the newer benzodiazepines. Clin. Pharmacokinet., 16, 337–364, 1989.

    Article  PubMed  CAS  Google Scholar 

  26. GILLIN J.C., MENDELSON W.B. - Neuropharmacology of central nervous system and behavioral disorders. 1st ed., Academic Press, New York, 1980.

    Google Scholar 

  27. GILLIN J.C., BYERLEY W.F. - The diagnosis and management of insomnia. N. Eng. J. Med., 332, 239–248, 1990.

    Google Scholar 

  28. GREENBLATT D.J., DIVOLL M., ABERNETHY D.R., OCHS H.R., SHADER R.I. - Benzodiazepine kinetics: Implication for therapeutics and pharmacogeriatrics. Drug. Metab. Rev., 14, 251–292, 1983.

    Article  PubMed  CAS  Google Scholar 

  29. GREENBLATT D.J., HARMATZ J.S., ENGELHARDT N., SHADER R.I. - Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Arch. Gen. Psychiatry, 46, 326–332, 1989.

    Article  PubMed  CAS  Google Scholar 

  30. GREENBLATT D.J., MILLER L.G., SHADER R.I. - Neurochemical and pharmacokinetic correlates of the clinical action of benzodiazepine hypnotic drugs. Amer. J. Med., 88 (suppl. 3A), 18S–24S, 1990.

    Article  Google Scholar 

  31. HARVEY S.C. - The pharmacological basis of therapeutics, 5th ed., MacMillan, New York, 1988.

    Google Scholar 

  32. HEDNER J., EMILIEN G., SALINAS E. - Improvement in sleep latency and sleep quality with zaleplon in elderly patients with primary insomnia. J. Sleep Res. 7 (Suppl. 2): 115, 1998.

    Google Scholar 

  33. HERRMANN W.M., DUBICKI S., WOBER W. - Zolpidem: a four week pilot polysomnographic study in patients with chronic sleep disturbances. In: Imidazopyridines in sleep disorders, J.P. Sauvanet, S.Z. Langer, P.L. Morselli (eds.). Raven Press, New York, 261–278, 1988.

    Google Scholar 

  34. HEYDORN W.E. - Zaleplon, a review of a novel sedative hypnotic used in the treatment of insomnia. Exp. Opin. Invest. Drugs 9, 841–858, 2000.

    Article  CAS  Google Scholar 

  35. HINDMARCH I. - Immediate and overnight effects of zopiclone 7,5 mg and nitrazepam 5 mg with ethanol, on psychomotor performance and memory in healthy volunteers. Int. Clin. Psychopharmacol., 5 (suppl. 2), 105–143, 1990.

    Google Scholar 

  36. HOHAGEN F., RINK K., KAPPLER C., SCHRAMM E., RIEMANN D., WEYERER S., BERGER M. -Prevalence and treatment of insomnia in general practice. Eur. Arch. Psychiatry Clin. Neurosc., 242, 329–336, 1993.

    Article  CAS  Google Scholar 

  37. HURST M., NOBLE S. - Zaleplon. CNS Drugs, 11,387–392,1999.

    Article  CAS  Google Scholar 

  38. JULOU L., BLANCHARD J.C., DREYFUS J.F. - Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone. Pharmacol. Biochem. Behav., 23, 653–659, 1985.

    Article  PubMed  CAS  Google Scholar 

  39. KALES A., KALES J.D. - Evaluation and treatment of insomnia, 1st ed. Oxford University Press, New York, 1984.

    Google Scholar 

  40. KUITUNEN T., MATTILA M.J., SEPPALA T. - Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. Int. J. Psychopharmacol., 5 (suppl. 2), 115–130, 1990.

    Google Scholar 

  41. LADER M., FRECKA G. - Subjective effects during and on discontinuation of zopiclone and of temazepam in healthy subjects. Pharmacopsychiatry, 20, 67–71, 1987.

    Article  PubMed  CAS  Google Scholar 

  42. MALEMAK M., SCIMA A., PRICE V. - Effects of zopiclone on the sleep of chronic insomniacs. Pharmacology, 27 (suppl. 2), 136–145, 1983.

    Google Scholar 

  43. MENDELSON W.B. - Use and misuse of sleeping pills: A clinical guide, 1st ed. Plenum Press, New York, 1980.

    Book  Google Scholar 

  44. MENDELSON W.B. - Pharmacotherapy of insomnia. Psychiat. Clin. North. Amer., 10, 555–563, 1987.

    CAS  Google Scholar 

  45. MITLER M.M., SEIDEL W.F., VAN DEN HOED J., GREENBLATT D.J., DEMENT W.C. - Comparative hypnotic effects of flurazepam, triazolam and placebo. A long-term simultaneous nighttime and daytime study. J. Clin. Psychopharmacol., 4, 2–13, 1984.

    Article  PubMed  CAS  Google Scholar 

  46. MONTI J.M. - Sleep laboratory and clinical studies of the effects of triazolam, flunitrazepam and flurazepam in insomniac patients. Meth. Find. Exp. Clin. Pharmacol., 3, 303–326, 1981.

    CAS  Google Scholar 

  47. MONTI J.M. - Concluding remarks. Toward a third generation of hypnotics. In: Imidazopyridines in sleep disorders. J.P. Sauvanet, S.Z. Langer, P.L. Morselli (eds.). Raven Press, New York, 365–368, 1988.

    Google Scholar 

  48. MONTI J.M. - Effects of zolpidem on sleep in insomniac patients. Eur. J. Clin. Pharmacol., 36,461–466, 1989.

    Article  PubMed  CAS  Google Scholar 

  49. MONTI J.M., ALTERWAIN P. - Short-term sleep laboratory evaluation of midazolam in chronic insomniacs. Preliminary results. Arzn. Forsch., 37, 54–57, 1987.

    CAS  Google Scholar 

  50. MONTI J.M., ALVARINO F., MONTI D. - Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia. Sleep, 23, 1075–1084, 2000

    PubMed  CAS  Google Scholar 

  51. MONTI J.M., ATTALI P., MONTI D., ZIPFEL A., DE LA GIGLAIS B., MORSELLI P.L. - Zolpidem and rebound insomnia - a double-blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiatry, 27, 166–175, 1994.

    Article  PubMed  CAS  Google Scholar 

  52. MONTI J.M., DEBELLIS J., GRATADOUX P., ALTERWAIN P., ALTIER H., D’ANGELO L. - Sleep laboratory study of the effects of midazolam in insomniac patients. Eur. J. Clin. Pharmacol., 21, 479–484, 1982.

    Article  PubMed  CAS  Google Scholar 

  53. MONTI J.M., MONTI D. - Pharmacological treatment of chronic insomnia. CNS Drugs. 4, 182–194, 1995.

    Article  CAS  Google Scholar 

  54. MONTI J.M., MONTI D., ESTEVEZ F., GIUSTI M. Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal. International Clinical Psychopharmacology, 11, 255–263, 1996

    Article  PubMed  CAS  Google Scholar 

  55. MONTI J.M., TRENCHI H.M., MORALES F., MONTI L. - Flunitrazepam (RO 5-4200) and sleep cycle in insomniac patients. Psychopharmacologia, 35, 371–379, 1974.

    Article  PubMed  CAS  Google Scholar 

  56. MOURET J., RUEL D., MAILLARD F., BIANCHI M. - Zopiclone versus triazolam in insomniac geriatric patients, Int. Clin. Psychopharmacol., 5 (suppl. 2), 47–55, 1990.

    Google Scholar 

  57. NICHOLSON A.N., PASCOE P.A. - Hypnotic activity of an imidazo-pyridine (zolpidem), Br. J. Clin. Pharmacol, 21, 205–211, 1986.

    Article  PubMed  CAS  Google Scholar 

  58. PATAT A., TROCHERIE S., THEBAULT J.J., ROSEN-ZWEIG P., DUBRUC C., BIANCHETTI G., COURT L.A., MORSELLI P.L. - EEG profile of intravenous zolpidem in healthy volunteers. Psychopharmacology, 114, 138–146, 1994.

    Article  PubMed  CAS  Google Scholar 

  59. PECKNOLD J., WILSON R., LE MORVAN P. - Long term efficacy and withdrawal of zopiclone. Int. Clin. Psychopharmacol., 5 (suppl. 2), 57–67, 1990.

    Google Scholar 

  60. QUADENS O.P., HOFFMAN G., BUYTAERT G. - Effects of zopiclone as compared to flurazepam in women over 40 years of age. Pharmacology, 27 (suppl. 2), 146–155,1983.

    Article  Google Scholar 

  61. RHODES S., PARRY P., HANNING C. - A double blind comparison of the effects of zolpidem and placebo on respiration during sleep in the elderly. Sleep Res., 18,69, 1989.

    Google Scholar 

  62. ROGER M., DALLOT J.Y., SALMON O., NEVEUX E., GITTON J.P., GERSON M., BROSSEL S., SAUVANET J.P. - Hypnotic effect of zolpidem in geriatric patients: a dose-finding study. In: Imidazopyridines in sleep disorders, J.P. Sauvanet, S.Z. Langer, P.L. Morselli (eds.). 1st ed. Raven Press, New York, 279–288, 1988.

    Google Scholar 

  63. RUSH C.R., FREY J.M., GRIFFITHS R.R. - Zaleplon and triazolam in humans: acute behavioral effects and abuse potential. Psychopharmacology, 145,39–51, 1999.

    Article  PubMed  CAS  Google Scholar 

  64. SANGER D.J., MOREL E., PERRAULT G. - Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur. J. Pharmacol 313, 35–42, 1996.

    Article  PubMed  CAS  Google Scholar 

  65. SAUVANET J.P., MAAREK L., ROGER M., RENAUDIN J., LOUVEL E., OROFIAMMA B. - Open long-term trials with zolpidem in insomnia. In: Imidazopyridines in sleep disorders, J.P. Sauvanet, S.Z. Langer, P.L. Morselli (eds.). Raven Press, New York, 339–350, 1988.

    Google Scholar 

  66. SCHARF M., VOGEL G., VERNON PEGRAM V., CATESBY WARE J., ROSE V., HOELSCHER V. - Dose-response effects of zolpidem in patients with chronic insomnia. Sleep Res., 19, 90, 1990.

    Google Scholar 

  67. SCHÖPF J. - Withdrawal phenomena after long-term administration of benzodiazepines. A review of recent investigations. Pharmacopsychiatria, 16, 1–8, 1983.

    Article  PubMed  Google Scholar 

  68. SULLIVAN G., MCBRIDE A.J., CLEE W.B. - Zopiclone abuse in South Wales: Three case reports. Human Psychopharmacol., 10, 351–352, 1995.

    Article  Google Scholar 

  69. THAKORE J., DINAN T.G. - Physical dependence following zopiclone usage: A case report. Human PsychopharmacoL, 7, 143–145, 1992.

    Article  Google Scholar 

  70. TRACHSEL L., DIJK D., BRUNNER D.P., KLENE C., BORBELY A.A. - Effects of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule. Neuropsychopharmacology, 3, 11–18, 1990.

    PubMed  CAS  Google Scholar 

  71. VERMEEREN A., DANJOU P.E., O’HANLON J.F. - Residual effects of evening and middle-of-the- night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Human psychopharmacol. 13, S98–S107, 1998

    Article  CAS  Google Scholar 

  72. WALSH J.K., FRY J., ERWIN C.W., SCHARF M., ROTH T., VOGEL G.W. - Efficacy and tolerability of 14-day administration of zaleplon 5 mg and 10 mg for the treatment of primary insomnia. Clin. Drug. Invest. 16, 347.354, 1998.

    Article  CAS  Google Scholar 

  73. WALSH J.K., VOGEL G.W., SCHARF M., ERMAN M., ERWIN C.W., SCHWEITZER P.K., MANGANO R.M., ROTH T. A five week polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. Sleep Medicine 1, 41–49, 2000

    Article  PubMed  Google Scholar 

  74. WORLD HEALTH ORGANIZATION - International statistical classification of diseases and related health problems (ICD-10). 10th ed., World Health Organization, Geneva, 1992.

    Google Scholar 

  75. ZIVKOVIC B., ARBILLA S. - Role of w receptor subtypes in the action of hypnotic drugs.Biol. Psychiat. Intern., Congress Series 1968, Excerpta Medica, Amsterdam, 1991.

    Google Scholar 

  76. ZIVKOVIC B., PERRAULT G., MOREL E., SANGER D.J. - Comparative pharmacology of zolpidem and other hypnotics and sleep inducers. In: Imidazopyridines in sleep disorders, J.P. Sauvanet, S.Z. Langer, P.L. Morselli (eds.). Raven Press, New York, 97–110, 1988.

    Google Scholar 

  77. ZIVKOVIC B., PERRAULT G., SANGER D.J. - Target receptors for anxiolytics and hypnotics: from molecular pharmacology to therapeutics. Karger, Basel, 1992.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departemento de Farmacologia y Terapeutica, Hospital de Clinicas, Montevideo, Uruguay

    J. M. Monti

Authors
  1. J. M. Monti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Gui de Chauliac, Montpellier, France

    Michel Billiard

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Monti, J.M. (2003). Benzodiazepines and new non-benzodiazepine agents. In: Billiard, M. (eds) Sleep. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0217-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0217-3_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4970-9

  • Online ISBN: 978-1-4615-0217-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation